RTsafe and Oncology Imaging Systems sign a distribution agreement
Athens, Greece - March 28, 2019 - RTsafe, a medical technology company focused on improving the safety and accuracy of radiotherapy for cancer and other medical conditions, today announced that it has signed Oncology Imaging Systems (OIS) as its exclusive distributor of PseudoPatient™ products for machine QA and patient QA for the United Kingdom.
Oncology Imaging Systems is a forward-thinking medical device company dedicated to providing the best products and the best customer service to the medical imaging, radiotherapy and medical physics communities. OIS specialises in patient positioning and immobilisation devices as well as radiation calibration and QA equipment for dosimetry, brachytherapy, intensity-modulated and image-guided radiotherapy, and stereotactic radiosurgery.
RTsafe is a medical technology company that has developed a unique approach to quality assurance that significantly enhances the safety and accuracy of radiotherapy for cancer and other medical conditions. It combines proven expertise in medical physics with highly accurate 3D printing technology to create pseudo‐in‐vivo dosimetry phantoms towards End‐to‐End commissioning, benchmarking and patient‐specific quality assurance in SRS, IMRT, VMAT and SBRT applications. The anatomically accurate effigies enable medical professionals to plan more precise treatment interventions for each individual patient and help radiotherapy technology innovators to fine‐tune their products. The result is more effective individualized therapy and reduced patient risk. For more information, visit www.rt-safe.com.